The trial uses an Apple smartwatch to monitor episodes of AFib, a heart rhythm disorder that can lead to blood clots and strokes. If patients are able to go 30 days without an episode, they can discontinue the use of blood thinners – while remaining monitored by the watch. — Photo by Angus Gray on Unsplash
After multiple medical procedures starting in May 2022, Arthur Schiebel was pleased to have his atrial fibrillation under control. He was less pleased to find out he’d need to take blood thinners twice a day – likely for the rest of his life – to reduce the risk of having a stroke.
"I'm not used to taking all this stuff," he thought at the time. "I just want to get off all this medication."
